Calculated Risk: The Projected Improvement in Life Expectancy.
underwriting
PodMed – Johns Hopkins 05.09.15 Medpage Today
PodMed: A Medical News Roundup From Johns Hopkins | Medpage Today.
Digoxin and mortality at the six minute mark of the podcast is a must listen.
Hemodialysis in Metformin Poisoning | The Poison Review
According to some reports metformin poisoning, though rare, is associated with a mortality rate of 30%.
via Hemodialysis in metformin poisoning | The Poison Review.
Yikes.
Intensive Tx Fails to Slow Atherosclerosis | Medpage Today
“When we see something that surprises us and flies in the face of what is understood, it requires another look — maybe a different cohort, larger numbers, longer follow-up,”
via Intensive Tx Fails to Slow Atherosclerosis | Medpage Today.
Surprised? As long as we continue to focus on pharmaceuticals as the answer, no one should be surprised.
Should patients stop taking aspirin for primary prevention? : Cleveland Clinic Journal of Medicine
More on the aspirin debate.
Should patients stop taking aspirin for primary prevention? : Cleveland Clinic Journal of Medicine.
Stroke Rounds: Opioids Linked to Afib | Medpage Today
Flakka – CSMonitor.com
27 Fatalities Lab-confirmed Exposure to PMMA (“Dr. Death”) | The Poison Review
27 fatalities from laboratory-confirmed exposure to PMMA (“Dr. Death”) | The Poison Review.
Meet “Dr. Death”: PMMA and PMA | The Poison Review.
Quote from one of the physicians in the video clip:
Your organs melt.
Increased Mortality Tied to Fatty Liver Disease Spectrum | Medpage Today
Hodgkin Lymphoma Survivors Need Long-Term Follow-Up for CVD | Medpage Today
Hodgkin lymphoma (HL) survivors experience increased risks of cardiovascular disease (CVD) for as long as 40 years after initial HL treatment, according to a Dutch study published online in JAMA Internal Medicine on April 27, 2015.
Furthermore, compared with the general population, HL patients run four- to almost seven-fold increased risks of coronary heart disease (CHD) or cardiomyopathy/congestive heart failure (HF) 35 years or more after treatment, resulting in 857 excess CV events per 10,000 person-years. More than half of patients with a CVD will experience multiple CV events over time.
via Hodgkin Lymphoma Survivors Need Long-Term Follow-Up for CVD | Medpage Today.
lifeunderwriter.net 
You must be logged in to post a comment.